Changes in choroidal thickness and choroidal vascularity index in thyroid eye disease: a systematic review

References

• Chin YH, Ng CH, Lee MH, Koh JWH, Kiew J, Yang SP. Prevalence of thyroid eye disease in Graves’ disease: a meta-analysis and systematic review. Clin Endocrinol (Oxf). 2020;93(4):363–374. doi:10.1111/cen.14296.
   PubMed Web of Science ®Google Scholar
• Perros P, Neoh C, Dickinson J. Thyroid eye disease. BMJ. 2009;338:b560. doi:10.1136/bmj.b560.
   PubMed Web of Science ®Google Scholar
• Mourits M, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 1997;47(1):9–14. doi:10.1046/j.1365-2265.1997.2331047.x.
   PubMed Web of Science ®Google Scholar
• Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velázquez-Villoria Á, Galofré JC. Graves’ ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. J Ophthalmol. 2015;2015:e249125. doi:10.1155/2015/249125.
   PubMed Web of Science ®Google Scholar
• Ponto KA, Pitz S, Pfeiffer N, Hommel G, Weber MM, Kahaly GJ. Quality of life and occupational disability in endocrine orbitopathy. Dtsch Ärztebl Int. 2009;106(17):283–289. doi:10.3238/arztebl.2009.0283.
   PubMed Web of Science ®Google Scholar
• Jonas JB, Forster TM, Steinmetz P, Schlichtenbrede FC, Harder BC. Choroidal thickness in age-related macular degeneration. Retina. 2014;34(6):1149–1155. doi:10.1097/IAE.0000000000000035.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Gupta P, Tan KA, Cheung CMG, Wong TY, Cheng CY. Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study. Sci Rep. 2016;6(1):21090. doi:10.1038/srep21090.
   PubMed Web of Science ®Google Scholar
• Iovino C, Pellegrini M, Bernabei F, Borrelli E, Sacconi R, Govetto A. Choroidal vascularity index: an in-depth analysis of this novel optical coherence tomography parameter. J Clin Med. 2020;9(2):595. doi:10.3390/jcm9020595.
   PubMed Web of Science ®Google Scholar
• Loiudice P, Pellegrini M, Marinò M, Mazzi B, Ionni I, Covello G. Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study. Eye Vis Lond Engl. 2021;8(1):18. doi:10.1186/s40662-021-00242-6.
   PubMedGoogle Scholar
• Ceylanoglu KS, Eser NA, Sen EM. Choroidal structural evaluation in inactive Graves’ ophthalmopathy. Photodiagnosis Photodyn Ther. 2022;39:103012. doi:10.1016/j.pdpdt.2022.103012.
   PubMed Web of Science ®Google Scholar
• Çalışkan S, Acar M, Gürdal C. Choroidal thickness in patients with Graves’ ophthalmopathy. Curr Eye Res. 2017;42(3):484–490. doi:10.1080/02713683.2016.1198488.
   PubMed Web of Science ®Google Scholar
• Nik N, Fong A, Derdzakyan M, Adamopoulou C, Sise A, Khanifar A. Changes in choroidal perfusion after orbital decompression surgery for Graves’ ophthalmopathy. J Ophthalmic Vis Res. 2017;12(2):183–186. doi:10.4103/jovr.jovr_165_16.
   PubMedGoogle Scholar
• Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. JBI Evid Implement. 2015;13(3):147–153. doi:10.1097/XEB.0000000000000054.
   Google Scholar
• Yu N, Zhang Y, Kang L, Gao Y, Zhang J, Wu Y. Analysis in choroidal thickness in patients with Graves’ ophthalmopathy using spectral-domain optical coherence tomography. J Ophthalmol. 2018;2018:e3529395. doi:10.1155/2018/3529395.
   PubMed Web of Science ®Google Scholar
• Gul A, Basural E, Ozturk HE. Comparison of choroidal thickness in patients with active and stable thyroid eye disease. Arq Bras Oftalmol. 2019;82(2):124–128. doi:10.5935/0004-2749.20190019.
   PubMed Web of Science ®Google Scholar
• Dave TV, Natarajan R, Reddy RU, Kapoor AG, Dave VP. Choroidal thickness in thyroid eye disease: comparison with controls and application in diagnosing non-inflammatory active disease. Cureus. 2021;13(11):e19779. doi:10.7759/cureus.19779.
   PubMed Web of Science ®Google Scholar
• Dave TV, Jonnadula GB, Lanka P, Natarajan R, Dave VP. Choroidal vascularity index in thyroid eye disease: comparison with controls and application in diagnosing non-inflammatory active disease. Orbit. 2022;41(1):89–96. doi:10.1080/01676830.2021.2014893.
   PubMed Web of Science ®Google Scholar
• Kong M, Choi DY, Han G, Song Y-M, Park SY, Sung J. Measurable range of subfoveal choroidal thickness with conventional spectral domain optical coherence tomography. Transl Vis Sci Technol. 2018;7(5):16. doi:10.1167/tvst.7.5.16.
   PubMed Web of Science ®Google Scholar
• Bruscolini A, La Cava M, Gharbiya M, Sacchetti M, Restivo L, Nardella C. Management of patients with Graves’ disease and orbital involvement: role of spectral domain optical coherence tomography. J Immunol Res. 2018;2018:1–6. doi:10.1155/2018/1454616.
   Web of Science ®Google Scholar
• Cagiltay E, Akay F, Demir O, Aydın E, Akmaz B, Pamuk B. The increment of choroidal thickness in euthyroid graves’ ophthalmopathy: is it an early sign of venous congestion? J Ophthalmol. 2018;2018:5891531. doi:10.1155/2018/5891531.
   PubMed Web of Science ®Google Scholar
• Del Noce C, Vagge A, Nicolò M, Traverso CE. Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and Angio-OCT. Graefes Arch Clin Exp Ophthalmol. 2020;258(5):1103–1107. doi:10.1007/s00417-020-04616-9.
   PubMed Web of Science ®Google Scholar
• Kim J, Yoon S, Baek S. Increase of central foveal and temporal choroidal thickness in patients with inactive thyroid eye disease. BMC Ophthalmol. 2021;21(1). doi:10.1186/s12886-021-01804-x.
   Web of Science ®Google Scholar
• Kurt MM, Akpolat C, Evliyaoglu F, Yilmaz M, Ordulu F. Evaluation of retinal neurodegeneration and choroidal thickness in patients with inactive Gravesʼ ophthalmopathy. Klin Monatsbl Augenheilkd. 2021;238(7):797–802. doi:10.1055/a-1275-0703.
   PubMed Web of Science ®Google Scholar
• Lai FHP, Iao TWU, Ng DSC, Young AL, Leung J, Au A. Choroidal thickness in thyroid-associated orbitopathy. Clin Exp Ophthalmol. 2019;47(7):918–924. doi:10.1111/ceo.13525.
   PubMed Web of Science ®Google Scholar
• Yeter V, Koçak N, Subaşı M, Parlak U. Choroidal vascularity index in thyroid-associated ophthalmopathy. Can J Ophthalmol J Can Ophtalmol. Published online July 26, 2021. doi:10.1016/j.jcjo.2021.06.023.
   Web of Science ®Google Scholar
• Yu L, Jiao Q, Cheng Y, Zhu Y, Lin Z, Shen X. Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography. BMC Ophthalmol. 2020;20(1). doi:10.1186/s12886-020-01692-7.
   Web of Science ®Google Scholar
• Ozturk Karabulut G, Fazil K, Ozturker C, Gunaydin ZK, Altan C, İ̇nal A. Do ocular pulse amplitude and choroidal thickness change in patients with thyroid eye disease? Orbit Lond. 2019;38(5):347–352. doi:10.1080/01676830.2018.1533568.
   PubMed Web of Science ®Google Scholar
• Özkan B, Koçer A, Altintaş, Karabaş L, Acar AZ, Yüksel N. Choroidal changes observed with enhanced depth imaging optical coherence tomography in patients with mild Graves orbitopathy. Eye Basingstoke. 2016;30(7):917–924. doi:10.1038/eye.2016.93.
   PubMed Web of Science ®Google Scholar
• Yıldırım G, Şahlı E, Alp MN. Evaluation of the effect of proptosis on choroidal thickness in graves’ ophthalmopathy. Turk J Ophthalmol. 2020;50(4):221–227. doi:10.4274/tjo.galenos.2020.97415.
   PubMedGoogle Scholar
• Fazil K, Ozturk Karabulut G, Alkin Z. Evaluation of choroidal thickness and retinal vessel density in patients with inactive Graves’ orbitopathy. Photodiagnosis Photodyn Ther. 2020;32:32. doi:10.1016/j.pdpdt.2020.101898.
   Web of Science ®Google Scholar
• Aksoy M, Simsek M, Apaydin M. Evaluation of choroidal circulation and stromal features in Graves’ disease. Eur J Ophthalmol. 2022;32(3):1680–1686. doi:10.1177/11206721211031406.
   PubMed Web of Science ®Google Scholar
• Steiner M, Esteban-Ortega MDM, Muñoz-Fernández S. Choroidal and retinal thickness in systemic autoimmune and inflammatory diseases: a review. Surv Ophthalmol. 2019;64(6):757–769. doi:10.1016/j.survophthal.2019.04.007.
   PubMed Web of Science ®Google Scholar
• Maruko I, Iida T, Sugano Y, Oyamada H, Sekiryu T, Fujiwara T. Subfoveal choroidal thickness after treatment of Vogt–koyanagi–Harada disease. Retina Phila Pa. 2011;31(3):510–517. doi:10.1097/IAE.0b013e3181eef053.
   PubMed Web of Science ®Google Scholar
• Kongwattananon W, Kumar A, Oyeniran E, Sen HN, Kodati S. Changes in choroidal vascularity index (CVI) in intermediate uveitis. Transl Vis Sci Technol. 2021;10(14):33. doi:10.1167/tvst.10.14.33.
   PubMed Web of Science ®Google Scholar
• Konuk O, Onaran Z, Ozhan Oktar S, Yucel C, Unal M. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves’ orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol. 2009;247(11):1555–1559. doi:10.1007/s00417-009-1144-0.
   PubMed Web of Science ®Google Scholar
• Somer D, Ozkan SB, Ozdemir H, Atilla S, Söylev MF, Duman S. Colour Doppler imaging of superior ophthalmic vein in thyroid-associated eye disease. Jpn J Ophthalmol. 2002;46(3):341–345. doi:10.1016/s0021-5155(02)00485-9.
   PubMed Web of Science ®Google Scholar
• Walasik-Szemplińska D, Pauk-Domańska M, Sanocka U, Sudoł-Szopińska I. Doppler imaging of orbital vessels in the assessment of the activity and severity of thyroid-associated orbitopathy. J Ultrason. 2015;15(63):388–397. doi:10.15557/JoU.2015.0036.
   PubMed Web of Science ®Google Scholar
• Baxter GM, Williamson TH. Color Doppler imaging of the eye: normal ranges, reproducibility, and observer variation. J Ultrasound Med. 1995;14(2):91–96. doi:10.7863/jum.1995.14.2.91.
   PubMed Web of Science ®Google Scholar
• Malamas A, Dervenis N, Kilintzis V, Chranioti A, Topouzis F. Inter- and intraobserver repeatability and reproducibility of choroidal thickness measurements using two different methods. Int Ophthalmol. 2019;39(5):1061–1069. doi:10.1007/s10792-018-0909-z.
   PubMed Web of Science ®Google Scholar
• Ulaş F, Dogan Ü, Dikbaş O, Çelebi S, Keleş A. Investigation of the choroidal thickness in patients with hypothyroidism. Indian J Ophthalmol. 2015;63(3):244. doi:10.4103/0301-4738.156976.
   PubMed Web of Science ®Google Scholar
• Kırıkkaya ET, Yılmaz Yaşar H. Oct findings and ocular changes in subclinical hypothyroidism. J Tepecik Educ Res Hosp. 2022;32(2):305–313. doi:10.4274/terh.galenos.2022.93206.
   Google Scholar